ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Okyo Pharma Limited

Okyo Pharma Limited (OKYO)

91.00
0.00
( 0.00% )
更新日時: 09:00:00

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
91.00
買値
1.20
売値
1.60
出来高
0.00
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
91.00
始値
-
時刻
(O)
最終取引時間
-
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

OKYO 最新ニュース

OKYO Pharma to Present at International Tear Film and Ocular Surface Society Conference

OKYO Pharma to Present at International Tear Film and Ocular Surface Society Conference LONDON and NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a...

OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain

OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain OK-101 is the first drug candidate to enroll patients specifically diagnosed with...

OKYO Pharma Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal Pain

OKYO Pharma Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal Pain Neuropathic corneal pain (NCP) is listed in the National Organization for Rare Disorders...

OKYO Pharma Announces Chairman Acquires Shares

OKYO Pharma Announces Chairman Acquires Shares LONDON and NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...

OKYO Pharma Announces Chairman Acquires Shares

OKYO Pharma Announces Chairman Acquires Shares LONDON and NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...

OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease

OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease LONDON and NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a...

OKYO Pharma CEO Interview to Air on Bloomberg TV

OKYO Pharma CEO Interview to Air on Bloomberg TV LONDON and NEW YORK, Aug. 23, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...

OKYO Pharma Announces Chairman Acquires Shares

OKYO Pharma Announces Chairman Acquires Shares LONDON and NEW YORK, Aug. 23, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...

OKYO Pharma Announces Chairman Acquires Shares

OKYO Pharma Announces Chairman Acquires Shares LONDON and NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...

OKYO Pharma Participates in H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

OKYO Pharma Participates in H.C. Wainwright 4th Annual Ophthalmology Virtual Conference LONDON and NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
QEDQuadrise Plc
4.00p
(73.91%)
42.75M
STKStreaksai Plc
0.275p
(25.00%)
4.59M
ORCPOracle Power Plc
0.0145p
(22.88%)
603.95M
PMGParkmead Group (the) Plc
15.25p
(15.09%)
592.17k
ROQRoquefort Therapeutics Plc
4.35p
(14.47%)
423.64k
INXI-nexus Global Plc
0.85p
(-73.02%)
2.8M
SFRSeverfield Plc
57.60p
(-33.94%)
3.19M
GWMOGreat Western Mining Corporation Plc
0.0165p
(-25.00%)
118.74M
MTCMothercare Plc
3.70p
(-12.94%)
100
ARVArtemis Resources Limited
0.55p
(-12.00%)
324.79k
NTVONativo Resources Plc
0.0025p
(0.00%)
2.07B
ORCPOracle Power Plc
0.0145p
(22.88%)
603.95M
CPXCap-xx Limited
0.1525p
(-8.96%)
261.25M
MSMNMosman Oil And Gas Limited
0.0385p
(0.00%)
182.71M
TRPTower Resources Plc
0.027p
(-1.82%)
156.66M

最近閲覧した銘柄

Delayed Upgrade Clock